Adjunctive therapies and immunomodulatory agents in the management of severe influenza
- 8 April 2013
- journal article
- review article
- Published by Elsevier in Antiviral Research
- Vol. 98 (3), 410-416
- https://doi.org/10.1016/j.antiviral.2013.03.019
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Association Between Use of Statins and Mortality Among Patients Hospitalized With Laboratory-Confirmed Influenza Virus Infections: A Multistate StudyThe Journal of Infectious Diseases, 2011
- CROSS-REACTIVE NEUTRALIZING ANTIBODY AGAINST PANDEMIC 2009 H1N1 INFLUENZA A VIRUS IN INTRAVENOUS IMMUNOGLOBULIN PREPARATIONSThe Pediatric Infectious Disease Journal, 2011
- Treating Viral Exacerbations of Chronic Obstructive Pulmonary Disease: Insights from a Mouse Model of Cigarette Smoke and H1N1 Influenza InfectionPLOS ONE, 2010
- Azithromycin attenuates airway inflammation in a mouse model of viral bronchiolitisRespiratory Research, 2010
- Outcomes of adults hospitalised with severe influenzaThorax, 2010
- Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus InfectionNew England Journal of Medicine, 2010
- Influenza Morbidity and Mortality in Elderly Patients Receiving Statins: A Cohort StudyPLOS ONE, 2009
- TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infectionProceedings of the National Academy of Sciences, 2009
- Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virusProceedings of the National Academy of Sciences, 2008
- Increased Survival after Gemfibrozil Treatment of Severe Mouse InfluenzaAntimicrobial Agents and Chemotherapy, 2007